References
- Capizzi R. L., Holcenberg J. S. Asparaginase. Cancer Medicine, 3rd Edition, Holland, Frei, 1992, In press
- From the files of Enzon, Inc., South Plainfield, New Jersey
- Wada H., Imamura I., Sako M., et al. Antitumor enzyme: Polyethylene glycol-modified asparaginase. Annals of the New York Academy of Sciences 1990; 613: 95–108
- MacEwen E. G., Rosenthal R., Matus R., et al. A preliminary study on the evaluation of asparaginase. Polyethylene glycol conjugate against canine malignant lymphoma. Cancer 1987; 59(12)2011–2015
- Muss H. B., Spell N., Scudiery D., Capizzi R. L., et al. A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkin's lymphoma. Investigational New Drugs 1990; 8(1)125–130
- Keating M. M. D. Anderson Cancer Center: Personal Communication
- Capizzi R. L. Asparaginase-methotrexate in combination chemotherapy: Schedule-dependent differential effects on normal versus neoplastic cells. Cancer Treat. Rep. 1981; 65(suppl 4)115–121
- Capizzi R. L., Davis R., Powell B., et al. Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia-a Cancer and Leukemia Group B Study. J. Clin. Oncol. 1988; 6: 499–508